Entering text into the input field will update the search result below

United Therapeutics surges 12% on Q3 beat as Tyvaso drives sales growth

Rolled newspaper with the headline Quarterly Results

Zerbor

  • United Therapeutics (NASDAQ:UTHR) stock soared ~12% on Wednesday after Q3 results surpassed analysts estimates.
  • GAAP EPS rose +43.57% Y/Y to $4.91. Total revenues grew +16% Y/Y to $516M.
  • "We are thrilled to report the highest quarterly revenue in our history," said United Chairperson

Recommended For You

About UTHR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
UTHR--
United Therapeutics Corporation